Emmanuel Frenehard, chief digital officer at Sanofi, believes the intersection of AI and pharma is where the magic happens.
As a biopharmaceutical giant, Sanofi is no stranger to innovative technologies, but with the rise of AI, the company’s chief digital officer Emmanuel Frenehard is recognizing new opportunities to drive progress in the industry. “Technology can accelerate the process of discovery,” Frenehard says. “By leveraging AI, we can find answers more quickly, and potentially develop new treatments sooner.” This isn’t just about saving time; it’s about saving lives.
Frenehard acknowledges that the role of chief digital officer (CDO) can vary greatly from company to company, but at Sanofi, it means embracing AI as a core part of the business. “As a CDO, my goal is to ensure that AI is used to its full potential within the organization,” he explains.
The Science Behind the Search
Sanofi is actively using AI to tackle some of the most challenging scientific questions facing the pharma industry. One of the key areas of focus is in the field of rare diseases, where AI can help identify potential treatments by analyzing vast amounts of data. This approach has resulted in some promising breakthroughs, says Frenehard. “We’ve seen AI identify some potential targets for rare diseases that we may not have otherwise discovered through traditional methods.”
The Human Touch
While AI is clearly playing a starring role in Sanofi’s research efforts, Frenehard emphasizes the importance of human intuition in the process. “AI is a tool, not a replacement for human insight,” he notes. By combining the strengths of both humans and AI, Sanofi is able to accelerate the pace of discovery without sacrificing the nuance and subtlety that only humans can bring.
What this means
The intersection of AI and pharma is a rapidly developing field, and Sanofi is at the forefront of this movement. As Emmanuel Frenehard sees it, the potential benefits for patients are vast. “By using AI to drive innovation, we can develop new treatments more quickly, and make them available to those who need them most.”
